NCBB Response to Updated FDA Guidance to Address the Need for Blood During the Pandemic
NCBB is very pleased with the modified rules for criteria to donate blood issued by the FDA on April 2, 2020. These changes, once implemented, will allow a wider group of potential donors to be eligible to give blood.
The changes will allow the following;
- HIV risk behavior deferrals will be shortened to 3 months
- Deferral for travel to an area of a country where there is a risk of contracting malaria will also be shortened to 3 months
- Deferral for time adding up to 5 years or more spent in European countries, previously considered to be a risk for contacting variant Creutzfeldt-Jacob Disease (vCJD) or the human version of Mad Cow Disease, will be eliminated. Please note that time adding up to 3 months or more in the UK is still a permanent deferral.
NOTE: These changes are not in place yet. It will take time for us to modify our computer systems, donor questionnaires and train staff to these newly published changes. Once that has happened we will revise our eligibility criteria and be able to accept newly eligible donors.